Applications of Non-invasive Neuromodulation for the Management of Disorders Related to COVID-19

Imagem de Miniatura
Arquivos
art_BAPTISTA_Applications_of_Noninvasive_Neuromodulation_for_the_Management_of_2020.PDF (1.22 MB)
Citações na Scopus
37
Tipo de produção
article
Data de publicação
2020
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
FRONTIERS MEDIA SA
Autores
BALTAR, Adriana
OKANO, Alexandre Hideki
MOREIRA, Alexandre
CAMPOS, Ana Carolina Pinheiro
BADRAN, Bashar W.
Citação
FRONTIERS IN NEUROLOGY, v.11, article ID 573718, 18p, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Novel coronavirus disease (COVID-19) morbidity is not restricted to the respiratory system, but also affects the nervous system. Non-invasive neuromodulation may be useful in the treatment of the disorders associated with COVID-19. Objective: To describe the rationale and empirical basis of the use of non-invasive neuromodulation in the management of patients with COVID-10 and related disorders. Methods: We summarize COVID-19 pathophysiology with emphasis of direct neuroinvasiveness, neuroimmune response and inflammation, autonomic balance and neurological, musculoskeletal and neuropsychiatric sequela. This supports the development of a framework for advancing applications of non-invasive neuromodulation in the management COVID-19 and related disorders. Results: Non-invasive neuromodulation may manage disorders associated with COVID-19 through four pathways: (1) Direct infection mitigation through the stimulation of regions involved in the regulation of systemic anti-inflammatory responses and/or autonomic responses and prevention of neuroinflammation and recovery of respiration; (2) Amelioration of COVID-19 symptoms of musculoskeletal pain and systemic fatigue; (3) Augmenting cognitive and physical rehabilitation following critical illness; and (4) Treating outbreak-related mental distress including neurological and psychiatric disorders exacerbated by surrounding psychosocial stressors related to COVID-19. The selection of the appropriate techniques will depend on the identified target treatment pathway. Conclusion: COVID-19 infection results in a myriad of acute and chronic symptoms, both directly associated with respiratory distress (e.g., rehabilitation) or of yet-to-be-determined etiology (e.g., fatigue). Non-invasive neuromodulation is a toolbox of techniques that based on targeted pathways and empirical evidence (largely in non-COVID-19 patients) can be investigated in the management of patients with COVID-19.
Palavras-chave
coronavirus, COVID-19, non-invasive vagus nerve stimulation, taVNS, tDCS, TMS, neuromodulation, NIBS
URI
https://observatorio.fm.usp.br/handle/OPI/39034
Referências
  1. Abboud FM, 2017, ADV PHYSIOL EDUC, V41, P578, DOI 10.1152/advan.00061.2017
  2. Abdullahi A, 2020, PHYSIOTHERAPY, V108, P1, DOI 10.1016/j.physio.2020.05.001
  3. Adair D, 2020, BRAIN STIMUL, V13, P717, DOI 10.1016/j.brs.2020.02.019
  4. Aftanas LI, 2018, B EXP BIOL MED+, V165, P195, DOI 10.1007/s10517-018-4128-4
  5. Ahmadizadeh MJ, 2019, BRAIN RES BULL, V153, P273, DOI 10.1016/j.brainresbull.2019.09.011
  6. Ahmadizadeh MJ, 2018, BRAIN RES BULL, V140, P334, DOI 10.1016/j.brainresbull.2018.06.001
  7. Algahtani H, 2016, CASE REP NEUROL MED, V2016, DOI 10.1155/2016/3502683
  8. Alix-Fages C, 2019, J CLIN MED, V8, DOI 10.3390/jcm8040536
  9. Allport LE, 2004, STROKE, V35, P1886, DOI 10.1161/01.STR.0000133687.33868.71
  10. Alonzo A, 2019, J AFFECT DISORDERS, V252, P475, DOI 10.1016/j.jad.2019.04.041
  11. Ammann C, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01981
  12. Andreis DT, 2016, INTENS CARE MED, V42, P1387, DOI 10.1007/s00134-016-4249-z
  13. ANDRIES K, 1980, AM J VET RES, V41, P1372
  14. Arabi YM, 2015, INFECTION, V43, P495, DOI 10.1007/s15010-015-0720-y
  15. Arbour N, 1999, J VIROL, V73, P3326, DOI 10.1128/JVI.73.4.3326-3337.1999
  16. Arbour N, 1999, J VIROL, V73, P3338, DOI 10.1128/JVI.73.4.3338-3350.1999
  17. Azabou E, 2013, RESP PHYSIOL NEUROBI, V189, P183, DOI 10.1016/j.resp.2013.07.024
  18. Badran B, 2017, BRAIN STIMUL, V10, P378
  19. Badran BW, 2019, JOVE-J VIS EXP, DOI 10.3791/58984
  20. Badran BW, 2018, BRAIN STIMUL, V11, P947, DOI 10.1016/j.brs.2018.06.003
  21. Badran BW, 2018, BRAIN STIMUL, V11, P492, DOI 10.1016/j.brs.2017.12.009
  22. Badran BW, 2018, BRAIN STIMUL, V11, P699, DOI 10.1016/j.brs.2018.04.004
  23. Baig AM, 2020, ACS CHEM NEUROSCI, V11, P995, DOI 10.1021/acschemneuro.0c00122
  24. Balasubramanian K, 2017, ANN INDIAN ACAD NEUR, V20, P403, DOI 10.4103/aian.AIAN_148_17
  25. Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340
  26. Barlow A, 2020, PHARMACOTHERAPY, V40, P416, DOI 10.1002/phar.2398
  27. Bassi GS, 2018, NEUROSCIENCE, V383, P191, DOI 10.1016/j.neuroscience.2018.05.008
  28. Ben Addi A, 2008, EUR J IMMUNOL, V38, P1610, DOI 10.1002/eji.200737781
  29. Bikson M, 2020, BRAIN STIMUL, V13, P1124, DOI 10.1016/j.brs.2020.05.010
  30. Bo Hai-Xin, 2020, Psychol Med, P1, DOI 10.1017/S0033291720000999
  31. do Nascimento IB, 2020, J CLIN MED, V9, DOI 10.3390/jcm9040941
  32. Borges H, 2020, JOVE-J VIS EXP, DOI 10.3791/59204
  33. Borovikova LV, 2000, NATURE, V405, P458
  34. Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8, 10.1016/S0140-6736(20)30460-8.]
  35. Brunoni AR, 2019, BRAZ J PSYCHIAT, V41, P70, DOI 10.1590/1516-4446-2017-0018
  36. Brunoni AR, 2017, JAMA PSYCHIAT, V74, P143, DOI 10.1001/jamapsychiatry.2016.3644
  37. Cao WJ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112934
  38. Cao YB, 2020, J AIR WASTE MANAGE, DOI [10.1002/jmv.25822, 10.1080/10962247.2020.1815895]
  39. Carnevali L, 2020, STRESS, V23, P26, DOI 10.1080/10253890.2019.1625884
  40. Cazet L, 2018, EXPERT OPIN DRUG MET, V14, P879, DOI 10.1080/17425255.2018.1496236
  41. Channappanavar R, 2017, SEMIN IMMUNOPATHOL, V39, P529, DOI 10.1007/s00281-017-0629-x
  42. Charvet LE, 2020, BRAIN STIMUL, V13, P686, DOI 10.1016/j.brs.2020.02.011
  43. Charvet LE, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00026
  44. Chavan SS, 2017, IMMUNITY, V46, P927, DOI 10.1016/j.immuni.2017.06.008
  45. Chen DB, 2020, INT J INFECT DIS, V93, P297, DOI 10.1016/j.ijid.2020.03.003
  46. Chiappelli F, 2020, BIOINFORMATION, V16, P288, DOI 10.6026/97320630016288
  47. Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216
  48. Cutsforth-Gregory JK, 2017, NEUROLOGY, V88, P1187, DOI 10.1212/WNL.0000000000003751
  49. D'Urso G, 2018, J ECT, V34, P172, DOI 10.1097/YCT.0000000000000538
  50. Dalli J, 2018, CURR OPIN IMMUNOL, V50, P48, DOI 10.1016/j.coi.2017.10.007
  51. Davidson JA, 2019, EXPERT REV ANTI-INFE, DOI 10.1080/14787210.2019.1689817
  52. de Lima AL, 2019, J AFFECT DISORDERS, V259, P31, DOI 10.1016/j.jad.2019.08.020
  53. Del Valle Diane Marie, 2020, medRxiv, DOI 10.1101/2020.05.28.20115758
  54. Demoule A, 2008, RESP PHYSIOL NEUROBI, V160, P172, DOI 10.1016/j.resp.2007.09.007
  55. Desforges M, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12010014
  56. Ding YQ, 2004, J PATHOL, V203, P622, DOI 10.1002/path.1560
  57. Dobbs B, 2018, J NEUROENG REHABIL, V15, DOI 10.1186/s12984-018-0457-9
  58. Donnelly WT, 2016, EXP PHYSIOL, V101, P946, DOI 10.1113/EP085716
  59. Driggin E, 2020, J AM COLL CARDIOL, V75, P2352, DOI 10.1016/j.jacc.2020.03.031
  60. Dyavanapalli J, 2016, CURR HYPERTENS REP, V18, DOI 10.1007/s11906-016-0630-0
  61. Fujii T, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01085
  62. Garg M, 2020, ALIMENT PHARM THER, V52, P569, DOI 10.1111/apt.15814
  63. Gault J, 1998, GENOMICS, V52, P173, DOI 10.1006/geno.1998.5363
  64. Ge LS, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00025
  65. Ghia JE, 2006, GASTROENTEROLOGY, V131, P1122, DOI 10.1053/j.gastro.2006.08.016
  66. Gianaros PJ, 2005, PSYCHOPHYSIOLOGY, V42, P627, DOI 10.1111/j.1469-8986.2005.00366.x
  67. Gu J, 2005, J EXP MED, V202, P415, DOI 10.1084/jem.20050828
  68. Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017
  69. Gurel NZ, 2020, BRAIN STIMUL, V13, P47, DOI 10.1016/j.brs.2019.08.002
  70. Gurel NZ, 2020, PSYCHIAT CLIN PSYCH, DOI [10.1101/2020.02.10.20021626, DOI 10.1101/2020.02.10.20021626]
  71. Guyenet PG, 2014, COMPR PHYSIOL, V4, P1511, DOI 10.1002/cphy.c140004
  72. Haensel A, 2008, PSYCHONEUROENDOCRINO, V33, P1305, DOI 10.1016/j.psyneuen.2008.08.007
  73. Harris-Love ML, 2006, ARCH PHYS MED REHAB, V87, pS84, DOI 10.1016/j.apmr.2006.08.330
  74. Hirfanoglu T, 2018, EPILEPSY BEHAV, V81, P33, DOI 10.1016/j.yebeh.2018.01.036
  75. Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
  76. Huang YH, 2020, BRAIN BEHAV IMMUN, V87, P149, DOI 10.1016/j.bbi.2020.05.012
  77. Huston JM, 2006, J EXP MED, V203, P1623, DOI 10.1084/jem.20052362
  78. Iseger TA, 2020, BRAIN STIMUL, V13, P1, DOI 10.1016/j.brs.2019.10.006
  79. Iseger TA, 2017, BRAIN STIMUL, V10, P1006, DOI 10.1016/j.brs.2017.05.002
  80. Jarchum I, 2011, CURR OPIN IMMUNOL, V23, P353, DOI 10.1016/j.coi.2011.03.001
  81. Jeong H, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016048
  82. Johnston GR, 2009, BRIT J ANAESTH, V102, P453, DOI 10.1093/bja/aep037
  83. Kalirathinam D, 2020, SCI MED, V30, DOI 10.15448/1980-6108.2020.1.38030
  84. Kamali AM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220363
  85. Kang LJ, 2020, BRAIN BEHAV IMMUN, V87, P11, DOI 10.1016/j.bbi.2020.03.028
  86. Khan M, 2020, INT J STROKE, V15, P699, DOI 10.1177/1747493020938285
  87. Kim JE, 2017, J CLIN NEUROL, V13, P227, DOI 10.3988/jcn.2017.13.3.227
  88. Kim YI, 2016, PSYCHIAT INVEST, V13, P622, DOI 10.4306/pi.2016.13.6.622
  89. Knotkova H, 2019, NEUROMODULATION, V22, P904, DOI 10.1111/ner.12786
  90. Kozel FA, 2019, PSYCHIAT RES, V273, P153, DOI 10.1016/j.psychres.2019.01.004
  91. Kreuzer PM, 2014, BRAIN STIMUL, V7, P740, DOI 10.1016/j.brs.2014.05.003
  92. Kreuzer Peter M, 2012, Front Psychiatry, V3, P70, DOI 10.3389/fpsyt.2012.00070
  93. Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976
  94. Lake MA, 2020, CLIN MED, V20, P124, DOI 10.7861/clinmed.2019-coron
  95. Lamb DG, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00124
  96. Lampert R, 2008, AM HEART J, V156, DOI 10.1016/j.ahj.2008.07.009
  97. Lane RD, 2009, NEUROIMAGE, V44, P213, DOI 10.1016/j.neuroimage.2008.07.056
  98. Lau KK, 2004, EMERG INFECT DIS, V10, P342, DOI 10.3201/eid1002.030638
  99. Laviolette L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062258
  100. Lee Dong-Jin, 2017, J Phys Ther Sci, V29, P527, DOI 10.1589/jpts.29.527
  101. Lefaucheur JP, 2020, CLIN NEUROPHYSIOL, V131, P1168, DOI 10.1016/j.clinph.2020.02.003
  102. Lefaucheur JP, 2017, NEUROPHYSIOL CLIN, V47, P173, DOI 10.1016/j.neucli.2017.03.003
  103. Lefaucheur JP, 2017, CLIN NEUROPHYSIOL, V128, P56, DOI 10.1016/j.clinph.2016.10.087
  104. Leung TW, 2005, ARCH NEUROL-CHICAGO, V62, P1113, DOI 10.1001/archneur.62.7.1113
  105. Li G, 2020, J MED VIROL, V92, P424, DOI 10.1002/jmv.25685
  106. Li YC, 2020, J MED VIROL, V92, P552, DOI 10.1002/jmv.25728
  107. Li YC, 2012, VIRUS RES, V163, P628, DOI 10.1016/j.virusres.2011.12.021
  108. Li YY, 2016, INTERVIROLOGY, V59, P163, DOI 10.1159/000453066
  109. Lin QQ, 2020, J MICROBIOL IMMUNOL, V53, P821, DOI 10.1016/j.jmii.2020.03.015
  110. Liu CH, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01732-5
  111. Liu NQ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112921
  112. Lu XL, 2011, VIRUS GENES, V42, P37, DOI 10.1007/s11262-010-0544-x
  113. Mahmudpour M, 2020, CYTOKINE, V133, DOI 10.1016/j.cyto.2020.155151
  114. Maier SF, 2005, NEUROSCI BIOBEHAV R, V29, P829, DOI 10.1016/j.neubiorev.2005.03.021
  115. Mak IWC, 2010, GEN HOSP PSYCHIAT, V32, P590, DOI 10.1016/j.genhosppsych.2010.07.007
  116. Mancia G, 2019, MANUAL HYPERTENSION, DOI [10.1201/9780429199189, DOI 10.1201/9780429199189]
  117. Manjili RH, 2020, J IMMUNOL, V205, P12, DOI 10.4049/jimmunol.2000413
  118. Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127
  119. Marin MF, 2014, DEPRESS ANXIETY, V31, P269, DOI 10.1002/da.22252
  120. Marvar PJ, 2012, PRIMER AUTONOMIC NER, P325, DOI [10.1016/B978-0-12-386525-0.00067-6, DOI 10.1016/B978-0-12-386525-0.00067-6]
  121. Mashimo M, 2017, LIFE SCI, V172, P13, DOI 10.1016/j.lfs.2016.12.015
  122. Mathern DR, 2015, CLIN J AM SOC NEPHRO, V10, P1636, DOI 10.2215/CJN.06230614
  123. Matsuda K, 2004, VET PATHOL, V41, P101, DOI 10.1354/vp.41-2-101
  124. Matthay MA, 2004, NAT MED, V10, P1161, DOI 10.1038/nm1104-1161
  125. McBride WT, 1996, ANAESTHESIA, V51, P465, DOI 10.1111/j.1365-2044.1996.tb07793.x
  126. McCray PB, 2007, J VIROL, V81, P813, DOI 10.1128/JVI.02012-06
  127. Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
  128. Milev RV, 2016, CAN J PSYCHIAT, V61, P561, DOI 10.1177/0706743716660033
  129. Mirakaj V, 2014, J EXP MED, V211, P1037, DOI 10.1084/jem.20132103
  130. Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748
  131. Montenegro RA, 2011, NEUROSCI LETT, V497, P32, DOI 10.1016/j.neulet.2011.04.019
  132. Morfopoulou S, 2016, NEW ENGL J MED, V375, P497, DOI 10.1056/NEJMc1509458
  133. Morya E, 2019, J NEUROENG REHABIL, V16, DOI 10.1186/s12984-019-0581-1
  134. Mudd Philip A, 2020, medRxiv, DOI 10.1101/2020.05.28.20115667
  135. Muhammad S, 2011, STROKE, V42, P783, DOI 10.1161/STROKEAHA.110.596783
  136. Nakayama T, 2004, J NEUROL, V251, P730, DOI 10.1007/s00415-004-0413-4
  137. Nance DM, 2007, BRAIN BEHAV IMMUN, V21, P736, DOI 10.1016/j.bbi.2007.03.008
  138. Napadow V, 2008, NEUROIMAGE, V42, P169, DOI 10.1016/j.neuroimage.2008.04.238
  139. Netland J, 2008, J VIROL, V82, P7264, DOI 10.1128/JVI.00737-08
  140. Ng WF, 2006, HUM PATHOL, V37, P381, DOI 10.1016/j.humpath.2006.01.015
  141. Nikolin S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181833
  142. Nilsson A, 2020, INFECT DIS-NOR, V52, P419, DOI 10.1080/23744235.2020.1729403
  143. Okano AH, 2017, INT J SPORTS MED, V38, P493, DOI 10.1055/s-0042-121897
  144. Okano AH, 2015, BRIT J SPORT MED, V49, P1213, DOI 10.1136/bjsports-2012-091658
  145. Olofsson PS, 2018, NEUROMODULATION COMP, P1483, DOI [10.1016/B978-0-12-805353-9.00125-X, DOI 10.1016/B978-0-12-805353-9.00125-X]
  146. Opal SM, 2005, CLIN INFECT DIS, V41, pS504, DOI 10.1086/432007
  147. OPPENHEIMER SM, 1992, NEUROLOGY, V42, P1727, DOI 10.1212/WNL.42.9.1727
  148. Palm U, 2018, NEUROMODULATION, V21, P323, DOI 10.1111/ner.12686
  149. Pavlov VA, 2006, BIOCHEM SOC T, V34, P1037, DOI 10.1042/BST0341037
  150. Pavlov VA, 2005, BRAIN BEHAV IMMUN, V19, P493, DOI 10.1016/j.bbi.2005.03.015
  151. Pena G, 2011, J IMMUNOL, V187, P718, DOI 10.4049/jimmunol.1100013
  152. Perera T, 2016, BRAIN STIMUL, V9, P336, DOI 10.1016/j.brs.2016.03.010
  153. Peuker ET, 2002, CLIN ANAT, V15, P35, DOI 10.1002/ca.1089
  154. Philip NS, 2019, AM J PSYCHIAT, V176, P939, DOI 10.1176/appi.ajp.2019.18101160
  155. Piccirillo G, 2016, CLIN INTERV AGING, V11, P1687, DOI 10.2147/CIA.S116194
  156. Ramos I, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00117
  157. Raux M, 2010, J APPL PHYSIOL, V108, P39, DOI 10.1152/japplphysiol.91454.2008
  158. Redgrave J, 2018, BRAIN STIMUL, V11, P1225, DOI 10.1016/j.brs.2018.08.010
  159. Regidor PA, 2020, MED HYPOTHESES, V142, DOI 10.1016/j.mehy.2020.109813
  160. Remue J, 2016, NEUROPSYCHOLOGY, V30, P756, DOI 10.1037/neu0000255
  161. Richardson JY, 2005, J IMMUNOL, V174, P4356, DOI 10.4049/jimmunol.174.7.4356
  162. Riggs A, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00093
  163. Rodrigues PA, 2019, NEUROPSYCH DIS TREAT, V15, P2743, DOI 10.2147/NDT.S201407
  164. Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985
  165. ROSENBAUM L, 2020, RECENT PROG MED, V111, P195, DOI 10.1056/NEJMp2005492
  166. Rosoman N, 2020, COVID 19 A COMPLEX M
  167. Rossi A, 2008, NEUROIMAG CLIN N AM, V18, P149, DOI 10.1016/j.nic.2007.12.007
  168. Rossi S, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0187
  169. Rousseau E, 2015, EXP PHYSIOL, V100, P566, DOI 10.1113/EP085005
  170. Saad M, 2014, INT J INFECT DIS, V29, P301, DOI 10.1016/j.ijid.2014.09.003
  171. Sandran N, 2019, J NEUROENG REHABIL, V16, DOI 10.1186/s12984-019-0529-5
  172. Sayad B, 2020, BLOOD COAGULATION PA
  173. Serhan CN, 2019, J INTERN MED, V286, P240, DOI 10.1111/joim.12871
  174. Serhan CN, 2018, MOL ASPECTS MED, V64, P1, DOI 10.1016/j.mam.2017.08.002
  175. Sharshar T, 2004, J APPL PHYSIOL, V97, P3, DOI 10.1152/japplphysiol.01099.2003
  176. Shaw M, 2020, MIL MED, V185, P319, DOI 10.1093/milmed/usz348
  177. Simpson R, 2020, AM J PHYS MED REHAB, V99, P470, DOI 10.1097/PHM.0000000000001443
  178. Smeeth L, 2005, ACC CURR J REV, V14, P12, DOI [10.1016/j.accreview.2005.02.064, DOI 10.1016/J.ACCREVIEW.2005.02.064]
  179. Staats PS, 2020, NEUROMODULATION, V23, P1044, DOI 10.1111/ner.13271
  180. Steardo L, 2020, ACTA PHYSIOL, V229, DOI 10.1111/apha.13473
  181. Stein DJ, 2020, NEUROPSYCH DIS TREAT, V16, P161, DOI 10.2147/NDT.S195840
  182. Sun PF, 2020, J MED VIROL, V92, P612, DOI 10.1002/jmv.25735
  183. Tan RST, 2013, IMMUNOL CELL BIOL, V91, P377, DOI 10.1038/icb.2013.13
  184. Tisoncik JR, 2012, MICROBIOL MOL BIOL R, V76, P16, DOI 10.1128/MMBR.05015-11
  185. Tomczak CR, 2013, J NEUROPHYSIOL, V110, P680, DOI 10.1152/jn.00723.2012
  186. Torabi A, 2020, ACS CHEM NEUROSCI, V11, P1909, DOI 10.1021/acschemneuro.0c00249
  187. Torres-Rosas R, 2014, NAT MED, V20, P291, DOI 10.1038/nm.3479
  188. Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566
  189. Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321
  190. Turgay C, 2015, J PEDIATR NEUROSCI, V10, P280, DOI 10.4103/1817-1745.165716
  191. Ulloa L, 2005, NAT REV DRUG DISCOV, V4, P673, DOI 10.1038/nrd1797
  192. Van Westerloo DJ, 2006, GASTROENTEROLOGY, V130, P1822, DOI 10.1053/j.gastro.2006.02.022
  193. van Westrenhen R, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00094
  194. Varatharaj A, 2017, BRAIN BEHAV IMMUN, V60, P1, DOI 10.1016/j.bbi.2016.03.010
  195. Vaseghi G, 2020, INFLAMMATORY MARKERS, DOI [10.1101/2020.04.29.20084863, DOI 10.1101/2020.04.29.20084863]
  196. Vink JJT, 2018, HUM BRAIN MAPP, V39, P4580, DOI 10.1002/hbm.24307
  197. von Weyhern CH, 2020, LANCET, V395, pE109, DOI 10.1016/S0140-6736(20)31282-4
  198. Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9
  199. Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124
  200. Wang H, 2003, J IMMUNOL, V171, P3823, DOI 10.4049/jimmunol.171.7.3823
  201. Wang HL, 2020, AGING-US, V12, P10022, DOI 10.18632/aging.103335
  202. Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
  203. WHO, COR
  204. WHO, 2020, WAT SAN HYG WAST MAN
  205. Wilcox SR, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1786
  206. Williamson JW, 2009, MED SCI SPORT EXER, V41, P574, DOI 10.1249/MSS.0b013e31818b98c8
  207. Williamson JW, 2004, J APPL PHYSIOL, V96, P719, DOI 10.1152/japplphysiol.00911.2003
  208. World Health Organization, 2020, RAT US PERS PROT EQ
  209. World Health Organization, 2020, MOD TRANSM VIR CAUS
  210. World Health Organization, 2013, WHO GUID HAND HYG HL
  211. World Health Organization, REPT WHO CHIN JOINT
  212. World Health Organization (WHO), 2020, COR
  213. Wu C, 2020, JAMA INTERN MED, V58, P713, DOI [10.1016/j.jemermed.2020.04.007, DOI 10.1016/J.JEMERMED.2020.04.007]
  214. Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994
  215. Wu YS, 2020, BRAIN BEHAV IMMUN, V87, P18, DOI 10.1016/j.bbi.2020.03.031
  216. Yamashita M, 2005, BIOCHEM BIOPH RES CO, V334, P79, DOI 10.1016/j.bbrc.2005.06.061
  217. Yan YQ, 2015, CELL, V160, P62, DOI 10.1016/j.cell.2014.11.047
  218. Ye MX, 2020, BRAIN BEHAV IMMUN, V88, P945, DOI [10.1016/j.bbi.2020.04.017, 10.1016/J.bbi.2020.04.017]
  219. Yi Y, 2020, INT J BIOL SCI, V16, P1753, DOI 10.7150/ijbs.45134
  220. Zeng FR, 2020, INT J INFECT DIS, V96, P467, DOI 10.1016/j.ijid.2020.05.055
  221. Zhang K, 2020, BRIT J PSYCHIAT, V217, P351, DOI 10.1192/bjp.2020.84
  222. Zheng ZH, 2020, J INFECTION, V81, pE16, DOI 10.1016/j.jinf.2020.04.021
  223. Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
  224. Zhou LY, 2020, TRAVEL MED INFECT DI, V36, DOI 10.1016/j.tmaid.2020.101642
  225. Zoccal DB, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00238

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - COVID-19
Artigos e Materiais de Revistas Científicas - FM/MFT
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/IPq
Carregar mais